The case report literature on GLP-1 agonists and anorgasmia identifies decreased norepinephrine signaling as a potential contributor to orgasmic dysfunction, which represents a separate but related concern from decreased desire
In clinical trials, serious side effects were rare and occurred at similar rates among those taking semaglutide and those taking a placebo
( B ) A similar pattern was observed for male transgenic mice treated with intranasal GHK-Cu compared to mice receiving intranasal saline at weeks 4 and 8
Abbott is identified as a leading player in the market, supported by its strong portfolio of advanced nutritional supplements including protein shakes, digestive health products, and glucose management solutions, continuous innovation in GLP1 companion formulations, and global presence across home consumption, clinical nutrition, and diabetes care programs.
While these medications can provide significant metabolic benefits, researchers are now taking a closer look at how rapid weight loss and GLP-1 therapies may affect bone health
